Botanical species · safety record

Anabasis aphylla

The EFSA Compendium of Botanicals holds 12 constituent measurements for Anabasis aphylla. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anabasis aphylla L.

12Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Anabasamine	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Anabasamine	—	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Isonicoteine	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
N-methylanabasine	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Quinolizidine alkaloids	—	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Anabasine	Live plants	Solvent extraction	≥ 0.06 Percent	—	No resolvable identifier
Anabasine	Live plants	Solvent extraction	≤ 3.2 Percent	—	No resolvable identifier
Lupinine	Live plants	Solvent extraction	1.5 Percent	—	No resolvable identifier
Pyridine alkaloids	Unspecified	—	—	—	No resolvable identifier
Quinolizidine alkaloids	Live plants	Solvent extraction	—	—	No resolvable identifier
Quinolizidine alkaloids	Unspecified	—	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Brutko, L. I., Massagetov, P. S. Lupinine content in Anabasis aphylla. Meditsinskaya promyshlennost sssr, 1964, vol. 18, no. 12, p. 34-5.
Sadykov, A. S., Aslanov, Kh. A., Kushmuradov, Yu. K. Quinolizidine alkaloids. Abhandlungen der deutschen akademie der wissenschaften zu berlin, klasse fuer chemie, geologie und biologie, 1966, vol. (3), p. 279-86.
Tilyabaev, Z., Abduvakhabov, A.A. Alkaloids of Anabasis aphylla and their cholinergic activities. Chemistry of natural compounds, 1998, vol. 34, no. 3, p. 295-297.
Du, Hua., Wang, Ye., Yan, Chen., Zhou, Li-Gang., Hao, Xiao-Jiang. Alkaloids from Anabasis aphylla L.. Journal of asian natural products research, 2008, vol. 10, no. 11, p. 1093-1095. DOI
Yusupov, Sh., Ishbaev, A.I., Aslanov, Kh.A., Sadykov, A.S. Quantitative determination of the alkaloids of Anabasis aphylla by thin-layer chromatography. Chemistry of natural compounds, 1976, vol. 12, no. 6, p. 692-695. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature